EL7.AI
StocksMedium•17 November 2026•
3 min read

Diploma lifts adjusted operating profit 42% to £487.1 million in FY26

Key Facts

1Diploma revenue rose 21% to £1,840.3 million in FY26.
2Adjusted operating profit increased 42% to £487.1 million, and the margin widened to 26.5%.
3Organic growth in Controls, which accounts for 61% of group revenue, was 25%.
4The company expects total growth of 12% and an operating margin of 25.5% in FY27.

Diploma reported preliminary results on 17 November 2026 for the financial year ended 30 September, recording a 42% increase in adjusted operating profit to £487.1 million. Revenue rose 21% to £1,840.3 million, from £1,524.5 million in the previous year. Organic revenue growth was 15%, compared with 11% in FY25. The adjusted operating margin widened to 26.5% from 22.5%, an increase of 400 basis points. Adjusted earnings per share also rose 45% to 255.6 pence, from 176.0 pence, in a year that combined sales growth with improved profitability.

Statutory operating profit rose to £390.0 million from £283.7 million in FY25. Adjusted return on trading capital increased to 25.3% from 20.9%, reflecting an improvement in returns on capital employed. The company said organic revenue growth of 15% came from exposure to attractive end markets, geographic expansion in its core markets and product extensions. It linked the wider margin to volume growth and the pass-through of input cost increases. In its results statement, the company said: "We achieved 15% organic growth in FY26." It added that the operating margin increased by 400 basis points to 26.5%, while operating profit rose 42%.

Controls was the largest sector growth driver, accounting for 61% of group revenue and delivering 25% organic growth. Diploma attributed the segment's performance to strong execution and demand in aerospace, defence, data centre and energy markets. The company said the rest of the portfolio, excluding Peerless, recorded organic growth of about 10%, while Peerless continued to support growth. Seals, which represents 26% of revenue, grew 4% organically, with sequential improvement in the second half of FY26. In Life Sciences, which contributes 13% of revenue, organic growth was limited to 1%, amid challenges in healthcare markets and short-term product lifecycle effects.

Acquisitions supported total revenue growth, with the group adding 16 companies since the start of FY26 for an investment of about £368 million. Diploma said the businesses contribute £50 million in annual operating profit, at an average multiple of about 7 times earnings before interest and tax. Deals included CDM, a US electrical connectors business serving the defence sector with revenue of about $80 million, and Elite, which specialises in aftermarket pump parts for the US market and has revenue of about $25 million. Total revenue growth thereby reached 21%, exceeding organic growth of 15%. The breakdown shows expansion came from a combination of growth in existing businesses and companies joining the group.

Free cash flow improved to £323.3 million, from £247.2 million in FY25, but earnings-to-cash conversion fell to 94% from 105%. Leverage declined to 0.7 times from 0.8 times. The board proposed total annual dividends of 65.4 pence per share, up 5% from 62.3 pence in the previous year. By comparison, FY25 revenue growth was 12%, including 11% organic growth, while adjusted operating profit then rose 20% to £342.7 million and the margin widened by 160 basis points to 22.5%. FY26 results show an acceleration in revenue and adjusted profit growth compared with those earlier rates.

Diploma expects total revenue growth of 12% at constant currency in FY27, comprising 6% organic growth and a 6% contribution from announced acquisitions. It is targeting an operating margin of 25.5%, below the 26.5% recorded in FY26. The company expects double-digit growth in the first quarter, followed by a moderation as it faces strong comparatives from the second quarter. Upcoming dates include publication of the annual report and accounts on 4 December 2026. The annual general meeting and first-quarter trading update are scheduled for 13 January 2027, with half-year results due on 18 May 2027.

Open on chart